So-Young Intl Stock Price, News & Analysis

So-Young International (NASDAQ: SY), China's largest medical aesthetics social community, has announced a rescheduling of its Q4 and full year 2024 financial results release. The results will now be presented before U.S. markets open on March 28, 2025, followed by a management earnings conference call at 7:30 AM U.S. Eastern Time (7:30 PM Beijing/Hong Kong Time) on the same day.

So-Young International (NASDAQ: SY), China's leading social community platform in the medical aesthetics industry, has announced it will release its Q4 and full year 2024 financial results on March 20, 2025, before U.S. markets open.

The company will host an earnings conference call on the same day at 7:30 AM U.S. Eastern Time (7:30 PM Beijing/Hong Kong Time). A telephone replay will be available until March 27, 2025, and interested parties can also access the webcast through the company's investor relations website.

So-Young International (NASDAQ: SY) announced its transfer from Nasdaq Global Market to Nasdaq Capital Market, effective February 27, 2025. This transition follows the company's non-compliance with Nasdaq's minimum bid price requirement, as its ADS price remained below $1.00 for 30 consecutive business days since August 29, 2024.

The transfer will not impact ADS trading, which continues under the symbol 'SY'. With this move, Nasdaq has granted So-Young an additional 180-day period until August 25, 2025, to regain compliance by maintaining a closing bid price above $1.00 for at least 10 consecutive business days. The company, China's largest medical aesthetics social community, is actively monitoring its ADS price and exploring options to address this deficiency.

So-Young International reported Q3 2024 financial results with total revenues of RMB371.8 million (US$53.0 million), down 3.5% year-over-year but exceeding guidance. Net income rose to RMB20.3 million (US$2.9 million), up from RMB18.3 million in Q3 2023. Sales of medical products grew 18.7% year-over-year, while information services revenue declined 8.0%. The company expanded its clinic network to 16 stores and improved operational efficiency, resulting in an 8.1% decrease in operating expenses. For Q4 2024, So-Young expects revenues between RMB350.0-370.0 million, representing a 5.3-10.4% year-over-year decrease.

So-Young International Inc. (NASDAQ: SY), China's largest medical aesthetics social community, has announced it will release its third quarter 2024 financial results on November 20, 2024, before U.S. markets open. The company will host an earnings conference call at 7:00 AM U.S. Eastern Time on the same day. A telephone replay will be available until November 27, 2024, and a webcast will be accessible through the company's investor relations website.

So-Young International Inc. (Nasdaq: SY), China's largest medical aesthetics social community, has received a notification from Nasdaq due to its American depositary shares (ADSs) closing bid price falling below $1.00 for 30 consecutive business days. This violates Nasdaq Listing Rule 5450(a)(1). The company has been given a 180-day compliance period until February 24, 2025, to regain compliance by maintaining a closing bid price of $1.00 or higher for at least ten consecutive business days. If unsuccessful, So-Young may be eligible for an additional 180-day period, subject to meeting other listing requirements. The company assures that this notice does not affect its current listing, trading, or business operations, and it will take all reasonable measures to regain compliance within the grace period.

So-Young International Inc. (Nasdaq: SY) reported its Q2 2024 financial results. Total revenues were RMB407.4 million (US$56.1 million), slightly down 1.1% year-over-year but exceeding guidance. The company achieved net income of RMB18.9 million (US$2.6 million), compared to a net loss in Q2 2023. Non-GAAP net income increased to RMB22.2 million (US$3.1 million).

Key highlights include a 22.6% increase in sales of medical products and maintenance services. The company opened 14 new clinics across eight core cities. However, average mobile MAUs decreased to 1.5 million from 3.0 million in Q2 2023. For Q3 2024, So-Young expects total revenues between RMB350.0 million and RMB370.0 million, representing a 9.2% to 4.0% year-over-year decrease.

So-Young International Inc. (NASDAQ: SY), China's largest social community for medical aesthetics, has announced it will report its Q2 2024 financial results on August 23, 2024, before U.S. markets open. The company will hold an earnings conference call at 7:30 AM U.S. Eastern Time (7:30 PM Beijing/Hong Kong Time) on the same day. Dial-in details for international, China, US, and Hong Kong participants are provided, along with a passcode. A telephone replay will be available until August 30, 2024. Additionally, a live and archived webcast of the conference call will be accessible at http://ir.soyoung.com.

So-Young International (Nasdaq: SY) reported financial results for Q1 2024. The company's total revenues increased to RMB318.3 million (US$44.1 million), a 2.6% rise year-over-year. However, the net loss rose to RMB21.2 million (US$2.9 million), compared to a net loss of RMB11.9 million in Q1 2023. Non-GAAP net income was RMB4.1 million (US$0.6 million), contrasting a non-GAAP net loss of RMB2.8 million the previous year.

Operational highlights include a drop in average mobile MAUs to 2.0 million from 3.4 million and a decrease in medical service providers on the platform to 1,160 from 1,419. Despite this, sales of medical products and maintenance services surged 23.3% to RMB86.5 million (US$12.0 million). The company also noted a significant increase in general and administrative expenses by 38.1%.

Looking forward, So-Young expects Q2 2024 revenues between RMB380.0 million (US$52.6 million) and RMB400.0 million (US$55.4 million), reflecting a potential year-over-year decrease.